Business Research Ethics
Business Research Ethics
Team A
RES/351
Business Research Ethics
Unethical behavior involved
GlaxoSmithKline (GSK) LLC unethical research behavior involved criminal and civil liabilities arising from the company’s illegal advertising of certain prescription drugs, its fiasco to report certain safety facts and its civil obligation for so-called false price reporting practices. This is the biggest health care fraud settlement in U.S. history and the largest payment by a drug company. As part of this global firmness, GSK has agreed to resolve its civil liability for the following alleged conduct: “(1) promoting the drugs Paxil, Wellbutrin, Advair, Lamictal and Zofran for off-label, non-covered uses and paying kickbacks to physicians to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex; (2) making false and misleading statements concerning the safety of Avandia; and (3) reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program” (Belkin, 2012) . Injured parties
The injured parties involved the masses of Americans who rest on programs like
Medicare and Medicaid. The multi-billion dollar payment is astonishing in both extent and range. This highlights the Administration’s strong obligation to defending the American people and holding liable those who make health care fraud.
The primary injured parties in this case would be the patients that were given the drugs and their families. The effects from the drugs given under false claims without disclosing the health risks caused undue injury and pain for the patients and families.
The secondary injured parties were the doctors and providers who unknowingly gave medication that would ultimately injure the patients. This includes the public health care service providers like the Veterans Administration, Medicaid, and Medicare.
The fraud and greed in this case also affected the third injured parties which are the families of the
Team A
RES/351
Business Research Ethics
Unethical behavior involved
GlaxoSmithKline (GSK) LLC unethical research behavior involved criminal and civil liabilities arising from the company’s illegal advertising of certain prescription drugs, its fiasco to report certain safety facts and its civil obligation for so-called false price reporting practices. This is the biggest health care fraud settlement in U.S. history and the largest payment by a drug company. As part of this global firmness, GSK has agreed to resolve its civil liability for the following alleged conduct: “(1) promoting the drugs Paxil, Wellbutrin, Advair, Lamictal and Zofran for off-label, non-covered uses and paying kickbacks to physicians to prescribe those drugs as well as the drugs Imitrex, Lotronex, Flovent and Valtrex; (2) making false and misleading statements concerning the safety of Avandia; and (3) reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program” (Belkin, 2012) . Injured parties
The injured parties involved the masses of Americans who rest on programs like
Medicare and Medicaid. The multi-billion dollar payment is astonishing in both extent and range. This highlights the Administration’s strong obligation to defending the American people and holding liable those who make health care fraud.
The primary injured parties in this case would be the patients that were given the drugs and their families. The effects from the drugs given under false claims without disclosing the health risks caused undue injury and pain for the patients and families.
The secondary injured parties were the doctors and providers who unknowingly gave medication that would ultimately injure the patients. This includes the public health care service providers like the Veterans Administration, Medicaid, and Medicare.
The fraud and greed in this case also affected the third injured parties which are the families of the